Literature DB >> 25356118

Semi-quantitative investigation of primary tumor and bone metastasis in lung cancer patients using the PET-CT approach.

Ozan Kandemir1, Kayhan Karakuş2, Ozgür Katrancioğlu3, Ali Sarikaya4.   

Abstract

BACKGROUND: Although advanced diagnostic and therapeutic development are achieved, lung cancer is the most leading cause of death. The stage of tumor is still the most important factor in determining the prognosis of cancer.
PURPOSE: The overarching goal of this study is to understand the relationship between the maximum standard uptake value (SUVmax) and bone metastasis using the PET-CT approach in lung cancer prognosis and survival research.
MATERIALS AND METHODS: The PET-CT analyses of previously diagnosed totally 86 lung cancer patients were retrospectively studied. Primer tumor standard uptake values for each patient were meticulously calculated and correlated with bone metastasis.
RESULTS: The demographics of the 86 patients is as follows; 79 man, 7 women with an age average of 59.44 ± 5.99, youngest being 46 and oldest 72. The number of small cell (SCC) and non-small cell lung cancer (NSCLC) patients were 10 (11.6%) and 76 (88.4%), respectively. Additionally, bone metastasis was detected in 35 (40.7%) patients. The patients were divided in 4 categories based on the observed primer tumor sizes of 0-3 cm (23.3%), 3-5 cm (27.9%), 5-7 cm (32.6%), and larger than 7 cm (16.3%). Patients with bone metastasis (35 in total) were divided in 2 categories based on the number of metastasis of being less than 3 (45.7%) and more than 3 (54.5%). We also used SUVmax values to clarify the study. 31.4% of the total patients had the SUVmax value lower than 10 and 68.6% of them had higher. 68.6% of the bone metastasis patients had SUV values lower than 8 and 31.4% of them had higher than 8.
CONCLUSION: The present study suggests a 27.2% positive relationship in primary tumor SUVmax value and tumor size. Although the average bone metastasis SUV with primary tumor SUV values higher than 10 is higher than the ones lower than 10, this difference did not generate a statistically significant data for cancer patients.

Entities:  

Keywords:  Bone metastasis; fluoro-2-deoxy-D-glucose positron emission tomography; lung cancer; standard uptake value

Year:  2014        PMID: 25356118      PMCID: PMC4211768     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  18 in total

1.  The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials.

Authors:  Ronald Boellaard; Wim J G Oyen; Corneline J Hoekstra; Otto S Hoekstra; Eric P Visser; Antoon T Willemsen; Bertjan Arends; Fred J Verzijlbergen; Josee Zijlstra; Anne M Paans; Emile F I Comans; Jan Pruim
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-08-15       Impact factor: 9.236

2.  Distribution of distant metastases from newly diagnosed non-small cell lung cancer.

Authors:  L E Quint; S Tummala; L J Brisson; I R Francis; A S Krupnick; E A Kazerooni; M D Iannettoni; R I Whyte; M B Orringer
Journal:  Ann Thorac Surg       Date:  1996-07       Impact factor: 4.330

3.  Evaluation of primary pulmonary carcinoid tumors using FDG PET.

Authors:  J J Erasmus; H P McAdams; E F Patz; R E Coleman; V Ahuja; P C Goodman
Journal:  AJR Am J Roentgenol       Date:  1998-05       Impact factor: 3.959

4.  Glucose transporters and FDG uptake in untreated primary human non-small cell lung cancer.

Authors:  R S Brown; J Y Leung; P V Kison; K R Zasadny; A Flint; R L Wahl
Journal:  J Nucl Med       Date:  1999-04       Impact factor: 10.057

5.  A correlation study between maximum standardized uptake values and pathology and clinical staging in nonsmall cell lung cancer.

Authors:  Peiou Lu; Lijuan Yu; Yingci Li; Yajuan Sun
Journal:  Nucl Med Commun       Date:  2010-07       Impact factor: 1.690

Review 6.  Evaluation and management of solitary and multiple pulmonary nodules.

Authors:  G A Lillington; C I Caskey
Journal:  Clin Chest Med       Date:  1993-03       Impact factor: 2.878

7.  Lung cancer proliferation correlates with [F-18]fluorodeoxyglucose uptake by positron emission tomography.

Authors:  H Vesselle; R A Schmidt; J M Pugsley; M Li; S G Kohlmyer; E Vallires; D E Wood
Journal:  Clin Cancer Res       Date:  2000-10       Impact factor: 12.531

8.  The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinoma.

Authors:  V Ahuja; R E Coleman; J Herndon; E F Patz
Journal:  Cancer       Date:  1998-09-01       Impact factor: 6.860

9.  Relationship between primary tumor fluorodeoxyglucose uptake and nodal or distant metastases at presentation in T1 stage non-small cell lung cancer.

Authors:  Minghuan Li; Ningbo Liu; Man Hu; Fang Shi; Shuanghu Yuan; Pinliang Zhang; Zheng Fu; Guoren Yang; Jinming Yu
Journal:  Lung Cancer       Date:  2008-07-16       Impact factor: 5.705

10.  The noninvasive staging of non-small cell lung cancer: the guidelines.

Authors:  Gerard A Silvestri; Lynn T Tanoue; Mitchell L Margolis; John Barker; Frank Detterbeck
Journal:  Chest       Date:  2003-01       Impact factor: 9.410

View more
  1 in total

1.  Genetic polymorphisms of IL-6 and IL-10 genes correlate with lung cancer in never-smoking Han population in China.

Authors:  Ying-Min Zhang; Yi-Min Mao; Yu-Xia Sun
Journal:  Int J Clin Exp Med       Date:  2015-01-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.